Get started
Author

Mathias Hoiczyk

Observed names: Hoiczyk, Mathias, M Hoiczyk, M. Hoiczyk, MATHIAS HOICZYK
OpenAlex ID: A5113611214
Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GIST): The EORTC STBSG Experience
2013 · Piotr Rutkowski, Alessandro Gronchi, et al. · Annals of Surgical Oncology · 248
Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib – Analysis of prognostic factors (EORTC-STBSG collaborative study)
2014 · S. Bauer, P. Rutkowski, et al. · European Journal of Surgical Oncology · 171
Significance of Folate Receptor Alpha and Thymidylate Synthase Protein Expression in Patients with Non–Small-Cell Lung Cancer Treated with Pemetrexed
2012 · Daniel C. Christoph, Bernadette Reyna Asuncion, et al. · Journal of Thoracic Oncology · 84
Therapeutic Potential of Mdm2 Inhibition in Malignant Germ Cell Tumours
2009 · Sebastian Bauer, Thomas Mühlenberg, et al. · European Urology · 51
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors
2014 · S Bauer, R A Hilger, et al. · British Journal of Cancer · 50
PDF
Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myeloma
2004 · P. Schütt, P. Ebeling, et al. · European Journal Of Haematology · 47
Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
2015 · Jens Köhler, Martin Schuler, et al. · Journal of Cancer Research and Clinical Oncology · 45
Neoadjuvant treatment improves capsular integrity and the width of the fibrous capsule of high-grade soft-tissue sarcomas
2012 · F. Grabellus, L.E. Podleska, et al. · European Journal of Surgical Oncology · 27
Trabectedin in metastatic soft tissue sarcomas: Role of pretreatment and age
2013 · MATHIAS HOICZYK, FLORIAN GRABELLUS, et al. · International Journal of Oncology · 23
PDF
Intimal sarcoma of the pulmonary artery with unusual findings: a case report
2012 · Mathias Hoiczyk, Konstantinos Iliodromitis, et al. · Clinical Research in Cardiology · 23
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial
2022 · Viktor Grünwald, Daniel Pink, et al. · Cancers · 15
PDF
A randomized, double-blind, phase III study comparing two doses of erlotinib for second-line treatment of current smokers with advanced non-small-cell lung cancer (CurrentS)
2016 · Egbert F. Smit, Yi-Long Wu, et al. · Lung Cancer · 14
Malignant pleural mesothelioma: initial experience in integrated 18F-FDG PET/MR imaging
2016 · Benedikt M. Schaarschmidt, Lino M. Sawicki, et al. · Clinical Imaging · 13
Brain metastases in sarcoma patients: Incidence and outcome.
2014 · Mathias Hoiczyk, Michael Herbrik, et al. · Journal of Clinical Oncology · 12
Real-World Efficacy of Docetaxel Plus Nintedanib After Chemo-Immunotherapy Failure in Advanced Pulmonary Adenocarcinoma
2021 · Martin Metzenmacher, Filippo Rizzo, et al. · Future Oncology · 8
Efficacy and safety results from CurrentS, a double-blind, randomized, phase III study of second-line erlotinib (150 mg versus 300 mg) in current smokers with advanced non-small cell lung cancer (NSCLC).
2014 · Egbert F. Smit, Radj Gervais, et al. · Journal of Clinical Oncology · 5
Arrhythmias in oncological patients: a compact overview for the clinician
2024 · Konstantinos Iliodromitis, Mathias Hoiczyk, et al. · Herzschrittmachertherapie + Elektrophysiologie · 4
Phase I trial of panobinostat (P) and imatinib (IM) in patients with treatment-refractory gastrointestinal stromal tumors (GIST).
2012 · Sebastian Bauer, Ralf A. Hilger, et al. · Journal of Clinical Oncology · 4
Rechallenge with ifosfamide-containing regimen as salvage option for patients with metastatic soft tissue sarcomas progressing after multiple pretreatments.
2012 · Mathias Hoiczyk, Petra Kuschel, et al. · Journal of Clinical Oncology · 3
A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer
2021 · Martin Metzenmacher, Hans-Georg Kopp, et al. · Therapeutic Advances in Medical Oncology · 2
PDF
1496P Trabectedin for patients with advanced soft tissue sarcoma: A non-interventional, prospective, multicenter study
2022 · V. Grünwald, D. Pink, et al. · Annals of Oncology · 1
PDF
1374P Docetaxel/nindetanib as efficient treatment option after failure of immune checkpoint inhibition: Real-world evidence
2020 · D.C.C. Christoph, F. Rizzo, et al. · Annals of Oncology · 1
PDF
Impact of EGFR Mutation Status on Clinical Benefit from BIBW 2992 in Patients (PTS) with Advanced Non-Small Cell Lung Cancer (NSCLC) Progressing After Chemotherapy (CTX) and Erlotinib (E) or Gefitinib (G) – A Single Center Experience
2012 · J. Köhler, K. Worm, et al. · Annals of Oncology · 1
PDF
Feasibility of evaluating AI-enabled digital symptom monitoring in metastatic patients with NSCLC receiving pembrolizumab therapy: A German single-arm observational pilot study
2025 · Melissa L. Santorelli, Oliver Schmalz, et al. · Digital Health
Correlation of proteomics and first-line platinum-based chemotherapy in stage III/IV NSCLC in a large single-center cohort.
2014 · Thomas Christoph Gauler, Lydia Espenhain, et al. · Journal of Clinical Oncology
Works count: 32
Citation count: 852
H-index: 13
I10-index: 14
Year
Topic
Type